Estradiol and progesterone-induced slowing of gonadotropin-releasing hormone pulse frequency is not reversed by subsequent administration of mifepristone
Subsequent to suppression of LH (GnRH) pulse frequency by progesterone (P) and estradiol (E 2 ), LH pulse frequency remains slow for 7 days after P withdrawal if mid-luteal E 2 concentrations are maintained. This may reflect an ability of E 2 to potentiate the suppressive effects of low P levels. We...
Saved in:
Published in | Endocrine Vol. 36; no. 2; pp. 239 - 245 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Boston
Springer US
01.10.2009
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Subsequent to suppression of LH (GnRH) pulse frequency by progesterone (P) and estradiol (E
2
), LH pulse frequency remains slow for 7 days after P withdrawal if mid-luteal E
2
concentrations are maintained. This may reflect an ability of E
2
to potentiate the suppressive effects of low P levels. We explored this notion in a similar experimental paradigm by administering a P-receptor antagonist (mifepristone) after P withdrawal while continuing E
2
. Studies were performed in seven ovulatory, non-obese women. Transdermal E
2
(0.2 mg/day) and oral micronized P (100 mg every 8 h) were started within 24 h of the LH surge and continued for 10 days. Subjects then underwent a 13-h blood sampling protocol for determination of LH pulse characteristics and various hormone concentrations. Oral P was then discontinued, and oral mifepristone (50, 100, or 200 mg daily) and transdermal E
2
(0.2 mg/day) were administered for 7 days, after which the above sampling protocol was repeated. Results with all mifepristone doses were similar and therefore pooled. Mean LH, LH amplitude, and mean FSH markedly decreased after 7 days of mifepristone, but LH pulse frequency did not change (3.3 ± 1.5 vs. 2.4 ± 1.5 pulses/13 h). Prolactin and androstenedione increased between the first and second admissions, with no changes in E
2
, cortisol, testosterone, or DHEAS. In conclusion, blockade of P action by mifepristone does not reverse a suppressed LH pulse frequency within 7 days when E
2
concentrations are maintained, suggesting that P withdrawal alone may not explain the luteal-follicular increase of GnRH pulse frequency. |
---|---|
AbstractList | Following suppression of LH (GnRH) pulse frequency by progesterone (P) and estradiol (E
2
), LH pulse frequency remains slow for 7 days after P withdrawal if mid-luteal E
2
concentrations are maintained. This may reflect an ability of E
2
to potentiate the suppressive effects of low P levels. We explored this notion in a similar experimental paradigm by administering a P-receptor antagonist (mifepristone) after P withdrawal while continuing E
2
. Studies were performed in seven ovulatory, non-obese women. Transdermal E
2
(0.2 mg/day) and oral micronized P (100 mg every 8 hours) were started within 24 hours of the LH surge and continued for 10 days. Subjects then underwent a 13-hour blood sampling protocol for determination of LH pulse characteristics and various hormone concentrations. Oral P was then discontinued, and oral mifepristone (50, 100, or 200 mg daily) and transdermal E
2
(0.2 mg/day) were administered for 7 days, after which the above sampling protocol was repeated. Results with all mifepristone doses were similar and therefore pooled. Mean LH, LH amplitude, and mean FSH markedly decreased after 7 days of mifepristone, but LH pulse frequency did not change (3.3 ± 1.5 vs. 2.4 ± 1.5 pulses/13 hours). Prolactin and androstenedione increased between the first and second admissions, with no changes in E
2
, cortisol, testosterone, or DHEAS. In conclusion, blockade of P action by mifepristone does not reverse a suppressed LH pulse frequency within 7 days when E
2
concentrations are maintained, suggesting that P withdrawal alone may not explain the luteal-follicular increase of GnRH pulse frequency. Subsequent to suppression of LH (GnRH) pulse frequency by progesterone (P) and estradiol (E(2)), LH pulse frequency remains slow for 7 days after P withdrawal if mid-luteal E(2) concentrations are maintained. This may reflect an ability of E(2) to potentiate the suppressive effects of low P levels. We explored this notion in a similar experimental paradigm by administering a P-receptor antagonist (mifepristone) after P withdrawal while continuing E(2). Studies were performed in seven ovulatory, non-obese women. Transdermal E(2) (0.2 mg/day) and oral micronized P (100 mg every 8 h) were started within 24 h of the LH surge and continued for 10 days. Subjects then underwent a 13-h blood sampling protocol for determination of LH pulse characteristics and various hormone concentrations. Oral P was then discontinued, and oral mifepristone (50, 100, or 200 mg daily) and transdermal E(2) (0.2 mg/day) were administered for 7 days, after which the above sampling protocol was repeated. Results with all mifepristone doses were similar and therefore pooled. Mean LH, LH amplitude, and mean FSH markedly decreased after 7 days of mifepristone, but LH pulse frequency did not change (3.3 +/- 1.5 vs. 2.4 +/- 1.5 pulses/13 h). Prolactin and androstenedione increased between the first and second admissions, with no changes in E(2), cortisol, testosterone, or DHEAS. In conclusion, blockade of P action by mifepristone does not reverse a suppressed LH pulse frequency within 7 days when E(2) concentrations are maintained, suggesting that P withdrawal alone may not explain the luteal-follicular increase of GnRH pulse frequency. Subsequent to suppression of LH (GnRH) pulse frequency by progesterone (P) and estradiol (E 2 ), LH pulse frequency remains slow for 7 days after P withdrawal if mid-luteal E 2 concentrations are maintained. This may reflect an ability of E 2 to potentiate the suppressive effects of low P levels. We explored this notion in a similar experimental paradigm by administering a P-receptor antagonist (mifepristone) after P withdrawal while continuing E 2 . Studies were performed in seven ovulatory, non-obese women. Transdermal E 2 (0.2 mg/day) and oral micronized P (100 mg every 8 h) were started within 24 h of the LH surge and continued for 10 days. Subjects then underwent a 13-h blood sampling protocol for determination of LH pulse characteristics and various hormone concentrations. Oral P was then discontinued, and oral mifepristone (50, 100, or 200 mg daily) and transdermal E 2 (0.2 mg/day) were administered for 7 days, after which the above sampling protocol was repeated. Results with all mifepristone doses were similar and therefore pooled. Mean LH, LH amplitude, and mean FSH markedly decreased after 7 days of mifepristone, but LH pulse frequency did not change (3.3 ± 1.5 vs. 2.4 ± 1.5 pulses/13 h). Prolactin and androstenedione increased between the first and second admissions, with no changes in E 2 , cortisol, testosterone, or DHEAS. In conclusion, blockade of P action by mifepristone does not reverse a suppressed LH pulse frequency within 7 days when E 2 concentrations are maintained, suggesting that P withdrawal alone may not explain the luteal-follicular increase of GnRH pulse frequency. |
Author | McCartney, Christopher R. Marshall, John C. Blank, Susan K. |
Author_xml | – sequence: 1 givenname: Christopher R. surname: McCartney fullname: McCartney, Christopher R. email: cm2hq@virginia.edu organization: Center for Research in Reproduction, University of Virginia Health System, Division of Endocrinology, Department of Internal Medicine, University of Virginia Health System – sequence: 2 givenname: Susan K. surname: Blank fullname: Blank, Susan K. organization: Center for Research in Reproduction, University of Virginia Health System, Division of Endocrinology, Department of Internal Medicine, University of Virginia Health System – sequence: 3 givenname: John C. surname: Marshall fullname: Marshall, John C. organization: Center for Research in Reproduction, University of Virginia Health System, Division of Endocrinology, Department of Internal Medicine, University of Virginia Health System |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/19609733$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kU1u3SAUhVGVqvlpF5BJxQZoLmBsM4lURUkbKVInrdQZwoAdIhtcsNO8pXS3wXlR00w6AnHu-c4V5xgdhBgcQqcUPlGA5ixTBgwIgCSSUUEe3qAjKoQkUOSDcudCFLX9eYiOc74DYIzVzTt0SGUNsuH8CP25zEvS1scR62DxnOLg8uJSCSI-2NU4i_MYf_sw4NjjIQZt45Li7ANJbnQ6b8ptTFNx4Hkds8N9cr9WF8wO-4xDXHBy9y7lQup2OK9dfpIXrO3kg9_yFx_Dhp987-ZUngrsPXrb64L78HyeoB9Xl98vvpKbb1-uLz7fEMMZX4ipLNSyt5a2nEGttRHARWsrYTmva2cMNbTjYBrmWC0r2XbcQCugEqySuucn6HzPndductaUzZIeVVlj0mmnovbqtRL8rRrivWKNaOsKCoDuASbFnJPr_3opqK0nte9JlZ7U1pN6KJ6P_4a-OJ6LKQNsP5CLFAaX1F1cUygf8R_qI1Qdpv4 |
Cites_doi | 10.1073/pnas.84.23.8745 10.1056/NEJM198701223160404 10.1210/jcem-64-4-675 10.1073/pnas.95.18.10978 10.1097/00003081-199606000-00017 10.1210/endo-109-2-376 10.1210/jcem.87.5.8484 10.1016/S0015-0282(16)49168-5 10.1016/S0015-0282(16)53174-4 10.1016/S0026-0495(97)90256-0 10.1016/S0015-0282(16)53457-8 10.1046/j.1365-2826.2001.00641.x 10.1093/oxfordjournals.humrep.a019174 10.1038/274276a0 10.1210/en.2002-220216 10.1016/S0015-0282(16)60067-5 10.1210/jcem.87.5.8510 10.1016/S0015-0282(16)58022-4 10.1016/S0010-7824(03)00171-9 10.1093/humrep/9.suppl_1.40 10.1016/j.steroids.2003.08.007 10.1210/jcem-58-2-378 10.1210/mend-3-8-1295 10.1210/endo-125-2-917 10.1210/jcem-65-6-1135 10.1210/jcem-66-3-508 10.1016/S0015-0282(16)54531-2 10.1210/jcem-69-1-67 10.1111/j.1365-2265.1990.tb00909.x 10.1172/JCI112883 10.1046/j.1365-2826.2000.00490.x 10.1073/pnas.84.21.7686 10.1016/S0002-9378(98)70483-1 10.1210/endo-109-5-1414 10.1016/j.ab.2008.07.001 10.1016/j.anireprosci.2006.09.015 10.1210/jcem-59-2-328 10.1210/jcem-61-3-484 10.1016/S0076-6879(04)84004-7 10.1016/0002-9378(90)90784-5 10.1016/S0015-0282(16)57678-X 10.1210/jcem-60-1-156 10.1016/S1016-8478(23)13478-9 10.1016/S0002-9378(87)80235-1 10.1210/jcem-62-6-1136 10.1210/endo-113-4-1333 10.1210/jcem.84.10.6079 |
ContentType | Journal Article |
Copyright | Springer Science+Business Media, LLC 2009 |
Copyright_xml | – notice: Springer Science+Business Media, LLC 2009 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 5PM |
DOI | 10.1007/s12020-009-9215-x |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1559-0100 |
EndPage | 245 |
ExternalDocumentID | 10_1007_s12020_009_9215_x 19609733 |
Genre | Clinical Trial Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NICHD NIH HHS grantid: K23 HD044742-03 – fundername: NICHD NIH HHS grantid: U54 HD28934 – fundername: NICHD NIH HHS grantid: U54 HD028934-14 – fundername: NICHD NIH HHS grantid: K23 HD044742 – fundername: NICHD NIH HHS grantid: F32 HD055014-02 – fundername: NICHD NIH HHS grantid: U54 HD028934-11 – fundername: NICHD NIH HHS grantid: K23 HD044742-02 – fundername: NCRR NIH HHS grantid: M01 RR000847-348637 – fundername: NICHD NIH HHS grantid: U54 HD028934-15 – fundername: NICHD NIH HHS grantid: K23 HD044742-05 |
GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C .86 .GJ .VR 06C 06D 0R~ 0VY 2.D 203 28- 29G 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2VQ 2~H 30V 4.4 406 408 40E 53G 5GY 5VS 78A 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AABYN AAFGU AAHNG AAIAL AAJKR AAKSU AANXM AANZL AAPBV AARHV AARTL AATNV AATVU AAUYE AAWCG AAYFA AAYIU AAYQN AAYTO ABDZT ABECU ABFGW ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKAS ABKCH ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTKH ABTMW ABWNU ABXPI ACBMV ACBRV ACBYP ACCUX ACGFO ACGFS ACHSB ACHXU ACIGE ACIPQ ACKNC ACMDZ ACMLO ACOKC ACOMO ACPRK ACREN ACSNA ACTTH ACUDM ACVWB ACWMK ADHHG ADHIR ADINQ ADJJI ADKNI ADKPE ADMDM ADOXG ADRFC ADTPH ADURQ ADYFF ADYOE ADZKW AEBTG AEEQQ AEFTE AEGAL AEGNC AEJHL AEJRE AEKMD AENEX AEOHA AEPYU AESKC AESTI AETLH AEVLU AEVTX AEXYK AFAFS AFEXP AFLOW AFNRJ AFQWF AFWTZ AFYQB AFZKB AGAYW AGDGC AGGBP AGGDS AGJBK AGKHE AGMZJ AGQMX AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHSBF AI. AIAGR AIAKS AIIXL AILAN AIMYW AITGF AJBLW AJDOV AJRNO AJZVZ AKMHD AKQUC ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMTXH AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBWZM BDATZ BGNMA CAG COF CS3 CSCUP DDRTE DNIVK DPUIP EBD EBLON EBS EIOEI EJD EMOBN ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GRRUI HF~ HG6 HMJXF HRMNR HVGLF HZ~ IJ- IKXTQ IMOTQ IWAJR IXD I~X I~Z J-C J0Z JBSCW JZLTJ KOV LLZTM M4Y MA- N2Q N9A NDZJH NF0 NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OVD P19 P2P P9S PF0 PT4 PT5 QOK QOR QOS R4E R89 R9I RHV RNI ROL RPX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TEORI TSG TT1 TUC U2A U9L UG4 UNUBA UOJIU UTJUX UZXMN VC2 VFIZW VH1 W48 WK8 YLTOR Z7U Z7W Z7X Z81 Z82 Z83 Z87 Z8O Z8V Z91 ZMTXR ZOVNA ZXP ~A9 ~EX ~KM AACDK AAEOY AAJBT AASML AAYZH ABAKF ACAOD ACDTI ACZOJ AEFQL AEMSY AFBBN AGQEE AGRTI AIGIU AJOOF CGR CUY CVF ECM EIF H13 NPM SJYHP AAYXX CITATION 5PM |
ID | FETCH-LOGICAL-c323t-c4d069fdd183206aac50358d45d3366ecc1c1b30c72e269498b3c085045249af3 |
IEDL.DBID | AGYKE |
ISSN | 1355-008X |
IngestDate | Tue Sep 17 20:41:50 EDT 2024 Fri Dec 06 06:08:15 EST 2024 Tue Oct 15 23:35:21 EDT 2024 Sat Dec 16 12:01:40 EST 2023 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Luteinizing hormone Luteal-follicular transition Mifepristone Gonadotropin-releasing hormone Progesterone Estradiol |
Language | English |
License | http://www.springer.com/tdm |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c323t-c4d069fdd183206aac50358d45d3366ecc1c1b30c72e269498b3c085045249af3 |
OpenAccessLink | https://europepmc.org/articles/pmc2758640?pdf=render |
PMID | 19609733 |
PageCount | 7 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_2758640 crossref_primary_10_1007_s12020_009_9215_x pubmed_primary_19609733 springer_journals_10_1007_s12020_009_9215_x |
PublicationCentury | 2000 |
PublicationDate | 2009-10-01 |
PublicationDateYYYYMMDD | 2009-10-01 |
PublicationDate_xml | – month: 10 year: 2009 text: 2009-10-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Boston |
PublicationPlace_xml | – name: Boston – name: United States |
PublicationTitle | Endocrine |
PublicationTitleAbbrev | Endocr |
PublicationTitleAlternate | Endocrine |
PublicationYear | 2009 |
Publisher | Springer US |
Publisher_xml | – name: Springer US |
References | GillSLavoieHBBo-AbbasYHallJEJ. Clin. Endocrinol. Metab.200287229723021:CAS:528:DC%2BD38XjsFGhu7c%3D10.1210/jc.87.5.229711994380 JohnsonMLVirostkoAVeldhuisJDEvansWSMethods Enzymol.200438440541:CAS:528:DC%2BD2cXjvFOqu7s%3D10.1016/S0076-6879(04)84004-715081680 LiuJHGarzoVGYenSSFertil. Steril.1988502452491:CAS:528:DyaL1cXlsVaktrY%3D2840310 DalkinACHaisenlederDJOrtolanoGAEllisTRMarshallJCEndocrinology19891259179241:CAS:528:DyaL1MXkvFSrsrw%3D10.1210/endo-125-2-9172502379 GoodmanRLBittmanELFosterDLKarschFJEndocrinology1981109141414171:CAS:528:DyaL38XhtVel10.1210/endo-109-5-14147297483 FilicoriMSantoroNMerriamGRCrowleyWFJrJ. Clin. Endocrinol. Metab.198662113611441:CAS:528:DyaL28XktFyru74%3D10.1210/jcem-62-6-11363084534 LiuJHGarzoGMorrisSStuenkelCUlmannAYenSSJ. Clin. Endocrinol. Metab.198765113511401:CAS:528:DyaL1cXjt1Wquw%3D%3D10.1210/jcem-65-6-11352824550 ScottCJPereiraAMTilbrookAJRawsonJAClarkeIJJ. Neuroendocrinol.2001134014061:CAS:528:DC%2BD3MXjtFOmtb4%3D10.1046/j.1365-2826.2001.00641.x11328448 MacLuskyNJMcEwenBSNature19782742762781:CAS:528:DyaE1MXhs1Glsg%3D%3D10.1038/274276a0683307 GrossKMMatsumotoAMBremnerWJJ. Clin. Endocrinol. Metab.1987646756801:CAS:528:DyaL2sXhs12nsrc%3D10.1210/jcem-64-4-6753102545 VermeulenAVerdonckLKaufmanJMJ. Clin. Endocrinol. Metab.199984366636721:CAS:528:DyaK1MXms1Ohtbs%3D10.1210/jc.84.10.366610523012 NippoldtTBReameNEKelchRPMarshallJCJ. Clin. Endocrinol. Metab.19896967761:CAS:528:DyaL1MXksFSltrg%3D10.1210/jcem-69-1-672499593 RobbinsASpitzIMClin. Obstet. Gynecol.1996394364501:STN:280:DyaK28zhvFagtw%3D%3D10.1097/00003081-199606000-000178734008 Sitruk-WareRSpitzIMContraception2003684094201:CAS:528:DC%2BD3sXpvF2rtLw%3D10.1016/S0010-7824(03)00171-914698070 WildtLHauslerAMarshallGHutchisonJSPlantTMBelchetzPEKnobilEEndocrinology19811093763851:CAS:528:DyaL3MXkvFWms7w%3D10.1210/endo-109-2-3766788538 SpitzIMSteroids2003689819931:CAS:528:DC%2BD3sXps1Olu7s%3D10.1016/j.steroids.2003.08.00714667991 KazemRMessinisLEFowlerPGroomeNPKnightPGTempletonAAHum. Reprod.199611258525901:CAS:528:DyaK2sXhs1Ojt70%3D9021355 HeikinheimoORantaSGrunbergSLahteenmakiPSpitzIMMetabolism1997462922961:CAS:528:DyaK2sXhvVSisbY%3D10.1016/S0026-0495(97)90256-09054472 GarzoVGLiuJUlmannABaulieuEYenSSJ. Clin. Endocrinol. Metab.1988665085171:CAS:528:DyaL1cXhsVelt70%3D10.1210/jcem-66-3-5082832438 GravanisASchaisonGGeorgeMde BruxJSatyaswaroopPGBaulieuEERobelPJ. Clin. Endocrinol. Metab.1985601561631:STN:280:DyaL2M%2FlsFCjsg%3D%3D10.1210/jcem-60-1-1563964788 VeldhuisJDCarlsonMLJohnsonMLProc. Natl Acad. Sci. USA198784768676901:CAS:528:DyaL1cXovVI%3D10.1073/pnas.84.21.76862823271 ScottCJPereiraAMRawsonJASimmonsDMRossmanithWGIngNHClarkeIJJ. Neuroendocrinol.2000125655751:CAS:528:DC%2BD3cXjsl2htb0%3D10.1046/j.1365-2826.2000.00490.x10844586 SoulesMRSteinerRACliftonDKCohenNLAkselSBremnerWJJ. Clin. Endocrinol. Metab.1984583783831:CAS:528:DyaL2cXotVWjuw%3D%3D10.1210/jcem-58-2-3786420438 StuenkelCAGarzoVGMorrisSLiuJHYenSSFertil. Steril.1990536426461:STN:280:DyaK3c3gtFCjsQ%3D%3D2156736 ShoupeDMishellDRJrFossumGBoppBLSpitzIMLoboRAAm. J. Obstet. Gynecol.1990163198219851:CAS:528:DyaK3MXisVSrsLk%3D2256511 RossmanithWGLiuCHLaughlinGAMortolaJFSuhBYYenSSClin. Endocrinol. (Oxf.)1990326476601:STN:280:DyaK3czgsFWqsQ%3D%3D10.1111/j.1365-2265.1990.tb00909.x BurgerLLDalkinACAylorKWHaisenlederDJMarshallJCEndocrinology2002143324332491:CAS:528:DC%2BD38XmsVSgt7o%3D10.1210/en.2002-22021612193535 ByrneBFowlerPATempletonAJ. Clin. Endocrinol. Metab.199681145414591:CAS:528:DyaK28Xit1OnsLo%3D10.1210/jc.81.4.14548636350 ReameNSauderSEKelchRPMarshallJCJ. Clin. Endocrinol. Metab.1984593283371:CAS:528:DyaL2cXltVCmsr8%3D10.1210/jcem-59-2-3286429184 KoeringMJHealyDLHodgenGDFertil. Steril.1986452802871:CAS:528:DyaL28Xhs1aitb0%3D3949027 MurphyAAKettelLMMoralesAJRobertsVJYenSSJ. Clin. Endocrinol. Metab.1993765135171:STN:280:DyaK3s7mtlagtg%3D%3D10.1210/jc.76.2.5138432797 NiemanLKChoateTMChrousosGPHealyDLMorinMRenquistDMerriamGRSpitzIMBardinCWBaulieuEEN. Engl. J. Med.19873161871911:CAS:528:DyaL2sXhtFelu7s%3D10.1056/NEJM1987012231604043796691 RomanoGJKrustAPfaffDWMol. Endocrinol.19893129513001:CAS:528:DyaL1MXlvVOktrg%3D10.1210/mend-3-8-12952779583 SchaisonGGeorgeMLestratNReinbergABaulieuEEJ. Clin. Endocrinol. Metab.1985614844891:CAS:528:DyaL2MXltFKntL4%3D10.1210/jcem-61-3-4842991322 HeikinheimoOPesonenUHuupponenRKouluMLahteenmakiPHum. Reprod.19949Suppl. 140461:CAS:528:DyaK2cXlvFKhurc%3D7962468 ShoupeDMishellDRJrLahteenmakiPHeikinheimoOBirgersonLMadkourHSpitzIMAm. J. Obstet. Gynecol.1987157141514201:CAS:528:DyaL1cXmvFWmtg%3D%3D2827481 SuganumaCKuroiwaTTanakaTKamomaeHAnim. Reprod. Sci.20071012852941:CAS:528:DC%2BD2sXot1yjt7k%3D10.1016/j.anireprosci.2006.09.01517027203 KaiserUBMol. Cells199886476561:CAS:528:DyaK1MXjvVOrsA%3D%3D9895115 SkinnerDCEvansNPDelaleuBGoodmanRLBouchardPCaratyAProc. Natl Acad. Sci. USA19989510978109831:CAS:528:DyaK1cXlvFWmt7c%3D10.1073/pnas.95.18.109789724815 KettelLMMurphyAAMoralesAJUlmannABaulieuEEYenSSFertil. Steril.19966523281:STN:280:DyaK287gvFShug%3D%3D8557150 SantoroNBanwellTTortorielloDLiemanHAdelTSkurnickJAm. J. Obstet. Gynecol.19981787327411:CAS:528:DyaK1cXjt12ls7k%3D10.1016/S0002-9378(98)70483-19579435 KettelLMMurphyAAMortolaJFLiuJHUlmannAYenSSFertil. Steril.1991564024071:STN:280:DyaK3Mznt1Chsw%3D%3D1716596 MurphyAAMoralesAJKettelLMYenSSFertil. Steril.1995641871901:STN:280:DyaK2MzgvFCntQ%3D%3D7789557 KarschFJFosterDLBittmanELGoodmanRLEndocrinology1983113133313391:CAS:528:DyaL3sXls12qsrw%3D10.1210/endo-113-4-13336684548 VeldhuisJDEvansWSRogolADThornerMOStumpfPJ. Clin. Invest.1987797697761:CAS:528:DyaL2sXhtlWqtL8%3D10.1172/JCI1128833818948 KesnerJSWilsonRCKaufmanJMHotchkissJChenYYamamotoHPardoRRKnobilEProc. Natl Acad. Sci. USA198784874587491:CAS:528:DyaL1cXjt1Wrsg%3D%3D10.1073/pnas.84.23.87453317420 JohnsonMLPipesLVeldhuisPPFarhyLSBoydDGEvansWSAnal. Biochem.20083818171:CAS:528:DC%2BD1cXhtVSitbnK10.1016/j.ab.2008.07.00118639514 WolfJPHsiuJGAndersonTLUlmannABaulieuEEHodgenGDFertil. Steril.198952105510601:STN:280:DyaK3c%2Fns1Ghuw%3D%3D2591563 McCartneyCRGingrichMBHuYEvansWSMarshallJCJ. Clin. Endocrinol. Metab.200287219422001:CAS:528:DC%2BD38XjsFGhurw%3D10.1210/jc.87.5.219411994363 2502379 - Endocrinology. 1989 Aug;125(2):917-24 9895115 - Mol Cells. 1998 Dec 31;8(6):647-56 3949027 - Fertil Steril. 1986 Feb;45(2):280-7 17027203 - Anim Reprod Sci. 2007 Oct;101(3-4):285-94 10844586 - J Neuroendocrinol. 2000 Jun;12(6):565-75 2991322 - J Clin Endocrinol Metab. 1985 Sep;61(3):484-9 2364566 - Clin Endocrinol (Oxf). 1990 May;32(5):647-60 9724815 - Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10978-83 9579435 - Am J Obstet Gynecol. 1998 Apr;178(4):732-41 11328448 - J Neuroendocrinol. 2001 May;13(5):401-6 7962468 - Hum Reprod. 1994 Jun;9 Suppl 1:40-6 3102545 - J Clin Endocrinol Metab. 1987 Apr;64(4):675-80 6420438 - J Clin Endocrinol Metab. 1984 Feb;58(2):378-83 10523012 - J Clin Endocrinol Metab. 1999 Oct;84(10):3666-72 3084534 - J Clin Endocrinol Metab. 1986 Jun;62(6):1136-44 2499593 - J Clin Endocrinol Metab. 1989 Jul;69(1):67-76 6684548 - Endocrinology. 1983 Oct;113(4):1333-9 2256511 - Am J Obstet Gynecol. 1990 Dec;163(6 Pt 1):1982-5 6429184 - J Clin Endocrinol Metab. 1984 Aug;59(2):328-37 2840310 - Fertil Steril. 1988 Aug;50(2):245-9 7297483 - Endocrinology. 1981 Nov;109(5):1414-7 2823271 - Proc Natl Acad Sci U S A. 1987 Nov;84(21):7686-90 2591563 - Fertil Steril. 1989 Dec;52(6):1055-60 12193535 - Endocrinology. 2002 Sep;143(9):3243-9 8636350 - J Clin Endocrinol Metab. 1996 Apr;81(4):1454-9 9021355 - Hum Reprod. 1996 Dec;11(12):2585-90 14698070 - Contraception. 2003 Dec;68(6):409-20 6788538 - Endocrinology. 1981 Aug;109(2):376-85 8432797 - J Clin Endocrinol Metab. 1993 Feb;76(2):513-7 18639514 - Anal Biochem. 2008 Oct 1;381(1):8-17 7789557 - Fertil Steril. 1995 Jul;64(1):187-90 2779583 - Mol Endocrinol. 1989 Aug;3(8):1295-300 9054472 - Metabolism. 1997 Mar;46(3):292-6 3796691 - N Engl J Med. 1987 Jan 22;316(4):187-91 2156736 - Fertil Steril. 1990 Apr;53(4):642-6 8734008 - Clin Obstet Gynecol. 1996 Jun;39(2):436-50 11994380 - J Clin Endocrinol Metab. 2002 May;87(5):2297-302 2832438 - J Clin Endocrinol Metab. 1988 Mar;66(3):508-17 3964788 - J Clin Endocrinol Metab. 1985 Jan;60(1):156-63 1716596 - Fertil Steril. 1991 Sep;56(3):402-7 15081680 - Methods Enzymol. 2004;384:40-54 11994363 - J Clin Endocrinol Metab. 2002 May;87(5):2194-200 2827481 - Am J Obstet Gynecol. 1987 Dec;157(6):1415-20 3317420 - Proc Natl Acad Sci U S A. 1987 Dec;84(23):8745-9 8557150 - Fertil Steril. 1996 Jan;65(1):23-8 2824550 - J Clin Endocrinol Metab. 1987 Dec;65(6):1135-40 3818948 - J Clin Invest. 1987 Mar;79(3):769-76 683307 - Nature. 1978 Jul 20;274(5668):276-8 14667991 - Steroids. 2003 Nov;68(10-13):981-93 LL Burger (9215_CR2) 2002; 143 R Sitruk-Ware (9215_CR23) 2003; 68 O Heikinheimo (9215_CR46) 1997; 46 RL Goodman (9215_CR10) 1981; 109 MJ Koering (9215_CR38) 1986; 45 O Heikinheimo (9215_CR42) 1994; 9 AA Murphy (9215_CR25) 1993; 76 JH Liu (9215_CR30) 1987; 65 GJ Romano (9215_CR13) 1989; 3 A Robbins (9215_CR41) 1996; 39 N Santoro (9215_CR17) 1998; 178 CR McCartney (9215_CR22) 2002; 87 D Shoupe (9215_CR28) 1990; 163 JP Wolf (9215_CR39) 1989; 52 VG Garzo (9215_CR29) 1988; 66 JD Veldhuis (9215_CR49) 1987; 84 FJ Karsch (9215_CR21) 1983; 113 CJ Scott (9215_CR14) 2000; 12 L Wildt (9215_CR5) 1981; 109 ML Johnson (9215_CR34) 2008; 381 B Byrne (9215_CR33) 1996; 81 UB Kaiser (9215_CR1) 1998; 8 DC Skinner (9215_CR9) 1998; 95 LM Kettel (9215_CR27) 1996; 65 N Reame (9215_CR7) 1984; 59 M Filicori (9215_CR6) 1986; 62 JS Kesner (9215_CR19) 1987; 84 TB Nippoldt (9215_CR11) 1989; 69 KM Gross (9215_CR4) 1987; 64 R Kazem (9215_CR32) 1996; 11 S Gill (9215_CR18) 2002; 87 JD Veldhuis (9215_CR16) 1987; 79 A Vermeulen (9215_CR48) 1999; 84 MR Soules (9215_CR8) 1984; 58 CJ Scott (9215_CR15) 2001; 13 WG Rossmanith (9215_CR20) 1990; 32 A Gravanis (9215_CR40) 1985; 60 NJ MacLusky (9215_CR12) 1978; 274 ML Johnson (9215_CR35) 2004; 384 D Shoupe (9215_CR44) 1987; 157 JH Liu (9215_CR45) 1988; 50 AA Murphy (9215_CR26) 1995; 64 IM Spitz (9215_CR36) 2003; 68 AC Dalkin (9215_CR3) 1989; 125 G Schaison (9215_CR31) 1985; 61 C Suganuma (9215_CR43) 2007; 101 LM Kettel (9215_CR47) 1991; 56 CA Stuenkel (9215_CR24) 1990; 53 LK Nieman (9215_CR37) 1987; 316 |
References_xml | – volume: 84 start-page: 8745 year: 1987 ident: 9215_CR19 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.84.23.8745 contributor: fullname: JS Kesner – volume: 316 start-page: 187 year: 1987 ident: 9215_CR37 publication-title: N. Engl. J. Med. doi: 10.1056/NEJM198701223160404 contributor: fullname: LK Nieman – volume: 64 start-page: 675 year: 1987 ident: 9215_CR4 publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jcem-64-4-675 contributor: fullname: KM Gross – volume: 95 start-page: 10978 year: 1998 ident: 9215_CR9 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.95.18.10978 contributor: fullname: DC Skinner – volume: 39 start-page: 436 year: 1996 ident: 9215_CR41 publication-title: Clin. Obstet. Gynecol. doi: 10.1097/00003081-199606000-00017 contributor: fullname: A Robbins – volume: 109 start-page: 376 year: 1981 ident: 9215_CR5 publication-title: Endocrinology doi: 10.1210/endo-109-2-376 contributor: fullname: L Wildt – volume: 87 start-page: 2194 year: 2002 ident: 9215_CR22 publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jcem.87.5.8484 contributor: fullname: CR McCartney – volume: 45 start-page: 280 year: 1986 ident: 9215_CR38 publication-title: Fertil. Steril. doi: 10.1016/S0015-0282(16)49168-5 contributor: fullname: MJ Koering – volume: 52 start-page: 1055 year: 1989 ident: 9215_CR39 publication-title: Fertil. Steril. doi: 10.1016/S0015-0282(16)53174-4 contributor: fullname: JP Wolf – volume: 46 start-page: 292 year: 1997 ident: 9215_CR46 publication-title: Metabolism doi: 10.1016/S0026-0495(97)90256-0 contributor: fullname: O Heikinheimo – volume: 53 start-page: 642 year: 1990 ident: 9215_CR24 publication-title: Fertil. Steril. doi: 10.1016/S0015-0282(16)53457-8 contributor: fullname: CA Stuenkel – volume: 13 start-page: 401 year: 2001 ident: 9215_CR15 publication-title: J. Neuroendocrinol. doi: 10.1046/j.1365-2826.2001.00641.x contributor: fullname: CJ Scott – volume: 11 start-page: 2585 year: 1996 ident: 9215_CR32 publication-title: Hum. Reprod. doi: 10.1093/oxfordjournals.humrep.a019174 contributor: fullname: R Kazem – volume: 274 start-page: 276 year: 1978 ident: 9215_CR12 publication-title: Nature doi: 10.1038/274276a0 contributor: fullname: NJ MacLusky – volume: 143 start-page: 3243 year: 2002 ident: 9215_CR2 publication-title: Endocrinology doi: 10.1210/en.2002-220216 contributor: fullname: LL Burger – volume: 50 start-page: 245 year: 1988 ident: 9215_CR45 publication-title: Fertil. Steril. doi: 10.1016/S0015-0282(16)60067-5 contributor: fullname: JH Liu – volume: 87 start-page: 2297 year: 2002 ident: 9215_CR18 publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jcem.87.5.8510 contributor: fullname: S Gill – volume: 65 start-page: 23 year: 1996 ident: 9215_CR27 publication-title: Fertil. Steril. doi: 10.1016/S0015-0282(16)58022-4 contributor: fullname: LM Kettel – volume: 68 start-page: 409 year: 2003 ident: 9215_CR23 publication-title: Contraception doi: 10.1016/S0010-7824(03)00171-9 contributor: fullname: R Sitruk-Ware – volume: 9 start-page: 40 issue: Suppl. 1 year: 1994 ident: 9215_CR42 publication-title: Hum. Reprod. doi: 10.1093/humrep/9.suppl_1.40 contributor: fullname: O Heikinheimo – volume: 81 start-page: 1454 year: 1996 ident: 9215_CR33 publication-title: J. Clin. Endocrinol. Metab. contributor: fullname: B Byrne – volume: 68 start-page: 981 year: 2003 ident: 9215_CR36 publication-title: Steroids doi: 10.1016/j.steroids.2003.08.007 contributor: fullname: IM Spitz – volume: 58 start-page: 378 year: 1984 ident: 9215_CR8 publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jcem-58-2-378 contributor: fullname: MR Soules – volume: 3 start-page: 1295 year: 1989 ident: 9215_CR13 publication-title: Mol. Endocrinol. doi: 10.1210/mend-3-8-1295 contributor: fullname: GJ Romano – volume: 125 start-page: 917 year: 1989 ident: 9215_CR3 publication-title: Endocrinology doi: 10.1210/endo-125-2-917 contributor: fullname: AC Dalkin – volume: 65 start-page: 1135 year: 1987 ident: 9215_CR30 publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jcem-65-6-1135 contributor: fullname: JH Liu – volume: 66 start-page: 508 year: 1988 ident: 9215_CR29 publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jcem-66-3-508 contributor: fullname: VG Garzo – volume: 56 start-page: 402 year: 1991 ident: 9215_CR47 publication-title: Fertil. Steril. doi: 10.1016/S0015-0282(16)54531-2 contributor: fullname: LM Kettel – volume: 69 start-page: 67 year: 1989 ident: 9215_CR11 publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jcem-69-1-67 contributor: fullname: TB Nippoldt – volume: 76 start-page: 513 year: 1993 ident: 9215_CR25 publication-title: J. Clin. Endocrinol. Metab. contributor: fullname: AA Murphy – volume: 32 start-page: 647 year: 1990 ident: 9215_CR20 publication-title: Clin. Endocrinol. (Oxf.) doi: 10.1111/j.1365-2265.1990.tb00909.x contributor: fullname: WG Rossmanith – volume: 79 start-page: 769 year: 1987 ident: 9215_CR16 publication-title: J. Clin. Invest. doi: 10.1172/JCI112883 contributor: fullname: JD Veldhuis – volume: 12 start-page: 565 year: 2000 ident: 9215_CR14 publication-title: J. Neuroendocrinol. doi: 10.1046/j.1365-2826.2000.00490.x contributor: fullname: CJ Scott – volume: 84 start-page: 7686 year: 1987 ident: 9215_CR49 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.84.21.7686 contributor: fullname: JD Veldhuis – volume: 178 start-page: 732 year: 1998 ident: 9215_CR17 publication-title: Am. J. Obstet. Gynecol. doi: 10.1016/S0002-9378(98)70483-1 contributor: fullname: N Santoro – volume: 109 start-page: 1414 year: 1981 ident: 9215_CR10 publication-title: Endocrinology doi: 10.1210/endo-109-5-1414 contributor: fullname: RL Goodman – volume: 381 start-page: 8 year: 2008 ident: 9215_CR34 publication-title: Anal. Biochem. doi: 10.1016/j.ab.2008.07.001 contributor: fullname: ML Johnson – volume: 101 start-page: 285 year: 2007 ident: 9215_CR43 publication-title: Anim. Reprod. Sci. doi: 10.1016/j.anireprosci.2006.09.015 contributor: fullname: C Suganuma – volume: 59 start-page: 328 year: 1984 ident: 9215_CR7 publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jcem-59-2-328 contributor: fullname: N Reame – volume: 61 start-page: 484 year: 1985 ident: 9215_CR31 publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jcem-61-3-484 contributor: fullname: G Schaison – volume: 384 start-page: 40 year: 2004 ident: 9215_CR35 publication-title: Methods Enzymol. doi: 10.1016/S0076-6879(04)84004-7 contributor: fullname: ML Johnson – volume: 163 start-page: 1982 year: 1990 ident: 9215_CR28 publication-title: Am. J. Obstet. Gynecol. doi: 10.1016/0002-9378(90)90784-5 contributor: fullname: D Shoupe – volume: 64 start-page: 187 year: 1995 ident: 9215_CR26 publication-title: Fertil. Steril. doi: 10.1016/S0015-0282(16)57678-X contributor: fullname: AA Murphy – volume: 60 start-page: 156 year: 1985 ident: 9215_CR40 publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jcem-60-1-156 contributor: fullname: A Gravanis – volume: 8 start-page: 647 year: 1998 ident: 9215_CR1 publication-title: Mol. Cells doi: 10.1016/S1016-8478(23)13478-9 contributor: fullname: UB Kaiser – volume: 157 start-page: 1415 year: 1987 ident: 9215_CR44 publication-title: Am. J. Obstet. Gynecol. doi: 10.1016/S0002-9378(87)80235-1 contributor: fullname: D Shoupe – volume: 62 start-page: 1136 year: 1986 ident: 9215_CR6 publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jcem-62-6-1136 contributor: fullname: M Filicori – volume: 113 start-page: 1333 year: 1983 ident: 9215_CR21 publication-title: Endocrinology doi: 10.1210/endo-113-4-1333 contributor: fullname: FJ Karsch – volume: 84 start-page: 3666 year: 1999 ident: 9215_CR48 publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jcem.84.10.6079 contributor: fullname: A Vermeulen |
SSID | ssj0022267 |
Score | 1.9178718 |
Snippet | Subsequent to suppression of LH (GnRH) pulse frequency by progesterone (P) and estradiol (E
2
), LH pulse frequency remains slow for 7 days after P withdrawal... Subsequent to suppression of LH (GnRH) pulse frequency by progesterone (P) and estradiol (E(2)), LH pulse frequency remains slow for 7 days after P withdrawal... Following suppression of LH (GnRH) pulse frequency by progesterone (P) and estradiol (E 2 ), LH pulse frequency remains slow for 7 days after P withdrawal if... |
SourceID | pubmedcentral crossref pubmed springer |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 239 |
SubjectTerms | Adult Circadian Rhythm - physiology Diabetes Drug Administration Routes Drug Administration Schedule Endocrinology Estradiol - administration & dosage Estradiol - adverse effects Estradiol - pharmacology Female Follicle Stimulating Hormone - blood Gonadotropin-Releasing Hormone - blood Gonadotropin-Releasing Hormone - metabolism Hormone Antagonists - administration & dosage Hormone Antagonists - adverse effects Hormone Antagonists - pharmacology Humanities and Social Sciences Humans Internal Medicine Luteinizing Hormone - blood Medicine Medicine & Public Health Mifepristone - administration & dosage Mifepristone - adverse effects Mifepristone - pharmacology multidisciplinary Original Paper Progesterone - administration & dosage Progesterone - adverse effects Progesterone - pharmacology Pulsatile Flow - drug effects Science Young Adult |
Title | Estradiol and progesterone-induced slowing of gonadotropin-releasing hormone pulse frequency is not reversed by subsequent administration of mifepristone |
URI | https://link.springer.com/article/10.1007/s12020-009-9215-x https://www.ncbi.nlm.nih.gov/pubmed/19609733 https://pubmed.ncbi.nlm.nih.gov/PMC2758640 |
Volume | 36 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3fb9MwED6NTUK8jLEBKz8mPyAeQK7SOHbixwp1m0DjiUrlKXLshFVjbtWkgvKf8N9y56StOuBhz76cHPnsu-_u_BngjVSW2gcVV0kleVKVmptMam4zrYpIWZ06SuhffVaX4-TjRE72IN6kLvxNf12RDAf19q5bTEiHcvka3RTHuPEAXQ9txoPhxddPow3MwoAiPKmCnhTFs8m6lvkvJTveaOOC7rZH3qmRBtdz_ri9DlgHxkLqOLnpL5uib3_9zed4j786gsMuEmXD1nSewF7pj-Fk6BGF367YWxZ6Q0PS_RgeXnUl-BP4PaLkiMMRZrxj1N8VyBZmvuSI79FSHKu_z37gLNisYt8w0kfgu6B7WZweaDGUnGDXGCrjF2y-RNfMqkXb0L1i05r5WcOIV2pRo6ZixWo82sJww8wO0y-pv51W5TzQI_jyKYzPR18-XPLufQduRSwabhMXKV05R8dKpIyxMhIyc4l0QiiFxjWwg0JENo1LunCrs0JYothLJIJGU4lnsO9R_SkwGRltC-10JYok1dboFCOvAcL7VJeIOXvwbr3O-byl8ci3hM20BjmuQU5rkP_swfPWALaixMuXCtGDdMc0NgJE0r074qfXgaw7RkCmkqgH79cGkHenRP3_Gby4l_RLeBRqXKHF8BXsN4tl-RpDpaY46_bGGTwYx8M_mPUQ3w |
link.rule.ids | 230,314,780,784,885,27924,27925,41081,41523,42150,42592,52111,52234 |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3Pb9MwFH5CQwIuCDZ-FAa8A-IAspTGsRMfq2lTB-tOq9Rb5NgJq7SlVZMJ-qfw3_Kem7TqxA6c7TiRPjvvfe_HZ4DPSjsuH9RCJ5USSVUaYTNlhMuMLiLtTOo5oD-51ONp8n2mZl0fd9NXu_cpyfCn3jW7xUx1OJhvyE4Jchwf04YzfG3BNB5tWRb5E-FGFTKkNDmb9anMfy2xZ4y2Fuh-deS9FGmwPGcv4HnnMuJog_FLeFTWh3A0qoku367xC4YizhAdP4Qnky5XfgR_TjmK4WkEbe2RC7GCKsKiLgURcYLUY3Oz-EXvxEWFP8klJ4a64gYqwTepWI4i4DX5tPQELu_IhmK12lRer3HeYL1okQWgVg2tVKyxoX9QGG7R7kny8vK386pcBh2DunwF07PTq5Ox6C5iEE7GshUu8ZE2lfd8_iNtrVORVJlPlJdSa9oFQzcsZOTSuOTOWJMV0rEWXqKI3dlKvoaDmpZ_C6gia1xhvKlkkaTGWZOSizQkHp6aksjhAL72iOTLjd5GvlNWZvhygi9n-PLfA3izgWo3lQX0UikHkO6BuJ3Aatr7I_X8Oqhqx8ScdBIN4FsPd94d5-bhL3j3X7M_wdPx1eQivzi__PEenoXEVKgLPIaDdnVXfiD_pi0-hv38FzlF9sY |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lj9MwEB6hRVpxQbDLozx9QBxA1qZx7MTHCrZaHrviQKXeIseO2Uq7btVkBf0p_FtmnKRVV3DgbMeJ9Dme-ebxGeCNVJbKBxVXmZc887XmppCa20KrKlFW544C-ucX6myWfZ7LeX_PaTNUuw8pya6ngVSaQnuycv5k1_iWEu2hwL5Gm8XRibxLlog2-iydbBkX-hbxdhU0qji5mA9pzb8tsWeYttbodqXkrXRptELTB3C_dx_ZpMP7IdypwxEcTwJS5-sNe8tiQWeMlB_B4XmfNz-G36cU0XA4wkxwjIqyokLCMtQcSTnC61hztfyJ72RLz36ge45sdU3NVJxuVTEUUWCX6N_iE2x1g_aU-XVXhb1hi4aFZctIDGrd4ErVhjV4HsXhlpk9eV5a_nrh61XUNAj1I5hNT79_OOP9pQzcilS03GYuUdo7R2dBooyxMhGycJl0QiiFO2Jsx5VIbJ7W1CWri0pY0sXLJDI948VjOAi4_FNgMjHaVtppL6os19boHN2lMXLyXNdIFEfwbkCkXHXaG-VOZZngKxG-kuArf43gSQfVbiqJ6eVCjCDfA3E7gZS190fC4jIqbKfIolSWjOD9AHfZ_9rNv7_g2X_Nfg2H3z5Oy6-fLr48h3sxRxVLBF_AQbu-qV-iq9NWr-J2_gMAdvsC |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Estradiol+and+progesterone-induced+slowing+of+gonadotropin-releasing+hormone+pulse+frequency+is+not+reversed+by+subsequent+administration+of+mifepristone&rft.jtitle=Endocrine&rft.au=McCartney%2C+Christopher+R.&rft.au=Blank%2C+Susan+K.&rft.au=Marshall%2C+John+C.&rft.date=2009-10-01&rft.issn=1355-008X&rft.eissn=1559-0100&rft.volume=36&rft.issue=2&rft.spage=239&rft.epage=245&rft_id=info:doi/10.1007%2Fs12020-009-9215-x&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s12020_009_9215_x |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1355-008X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1355-008X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1355-008X&client=summon |